Surrozen (SRZN) Common Equity (2020 - 2026)
Surrozen's Common Equity was -$218.67 million in Q2 2026, compared with $47.11 million a year earlier.
Analysis
Surrozen (SRZN) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Surrozen came in at -$187.76 million.
- In earlier years, Common Equity was -$21.38 million in FY2024, $37.94 million in FY2023 (-50.1%), $76 million in FY2022 (-30.7%) and $109.7 million in FY2021 (+132.0%).
- Quarterly Common Equity has moved between -$278.15 million (Q1 2026) and $123.73 million (Q3 2021) over five years.
- The best year-over-year quarter for Common Equity over five years was Q2 2025 (growth of 677.2%); the worst was Q2 2024 (a decline of 89.0%).
- Per Business Quant data, SRZN's Common Equity in the three quarters before Q2 2026 was -$278.15 million (Q1 2026), -$187.76 million (Q4 2025) and -$23.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Surrozen | 375.89 Mn | 375.89 Mn | - | -218.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -218.67 Mn |
| Mar 31, 2026 | -278.15 Mn |
| Dec 31, 2025 | -187.76 Mn |
| Sep 30, 2025 | -23.52 Mn |
| Jun 30, 2025 | 47.11 Mn |
| Mar 31, 2025 | 5.67 Mn |
| Dec 31, 2024 | -21.38 Mn |
| Sep 30, 2024 | 5.67 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 30.14 Mn |
| Dec 31, 2023 | 37.94 Mn |
| Sep 30, 2023 | 45.53 Mn |
| Jun 30, 2023 | 55.06 Mn |
| Mar 31, 2023 | 63.04 Mn |
| Dec 31, 2022 | 76.00 Mn |
| Sep 30, 2022 | 77.49 Mn |
| Jun 30, 2022 | 89.70 Mn |
| Mar 31, 2022 | 102.66 Mn |
| Dec 31, 2021 | 109.70 Mn |
| Sep 30, 2021 | 123.73 Mn |
API Access
Surrozen Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SRZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();